{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,3]],"date-time":"2022-04-03T12:06:08Z","timestamp":1648987568110},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,2,19]],"date-time":"2014-02-19T00:00:00Z","timestamp":1392768000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Herzschr Elektrophys"],"published-print":{"date-parts":[[2014,3]]},"DOI":"10.1007\/s00399-014-0300-3","type":"journal-article","created":{"date-parts":[[2014,2,18]],"date-time":"2014-02-18T08:15:48Z","timestamp":1392711348000},"page":"19-25","source":"Crossref","is-referenced-by-count":0,"title":["Medikament\u00f6se Rhythmuskontrolle bei Vorhofflimmern"],"prefix":"10.1007","volume":"25","author":[{"given":"Bernd","family":"Nowak","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander","family":"F\u00fcrnkranz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,2,19]]},"reference":[{"key":"300_CR1","doi-asserted-by":"crossref","unstructured":"Tsadok MA, Jackevicius CA, Essebag V, Eisenberg MJ, Rahme E, Humphries KH, Tu JV, Behlouli H, Pilote L (2012) Rhythm versus rate control therapy and subsequent stroke or transient ischemic attack in patients with atrial fibrillation. Circulation 126:2680\u20132687","DOI":"10.1161\/CIRCULATIONAHA.112.092494"},{"key":"300_CR2","doi-asserted-by":"crossref","unstructured":"Ionescu-Ittu R (2012) Comparative effectiveness of rhythm control vs rate control drug treatment effect on mortality in patients with atrial fibrillation. Arch Intern Med 172:997","DOI":"10.1001\/archinternmed.2012.2266"},{"key":"300_CR3","doi-asserted-by":"crossref","unstructured":"Camm AJ, Kirchhof P, Lip GYH, Schotten U, Savelieva I, Ernst S, Gelder IC Van, Al-Attar N, Hindricks G, Prendergast B, Heidbuchel H, Alfieri O, Angelini A, Atar D, Colonna P, Caterina R De, Sutter J De, Goette A, Gorenek B, Heldal M, Hohloser SH, Kolh P, Heuzey J-Y Le, Ponikowski P, Rutten FH (2010) Guidelines for the management of atrial fibrillation: the task force for the management of atrial fibrillation of the European Society of Cardiology (ESC). Eur Heart J 31:2369\u20132429","DOI":"10.1093\/eurheartj\/ehq278"},{"key":"300_CR4","doi-asserted-by":"crossref","unstructured":"Fink A, Ehrlich J (2012) Antiarrhythmische Therapie bei Vorhofflimmern. Aktuelle Kardiologie 1:185\u2013191","DOI":"10.1055\/s-0032-1315039"},{"key":"300_CR5","doi-asserted-by":"crossref","unstructured":"Zimetbaum P (2012) Antiarrhythmic drug therapy for atrial fibrillation. Circulation 125:381\u2013389","DOI":"10.1161\/CIRCULATIONAHA.111.019927"},{"key":"300_CR6","doi-asserted-by":"crossref","unstructured":"Roy D, Pratt CM, Torp-Pedersen C, Wyse DG, Toft E, Juul-Moller S, Nielsen T, Rasmussen SL, Stiell IG, Coutu B, Ip JH, Pritchett ELC, Camm AJ, Atrial Arrhythmia Conversion Trial Investigators (2008) Vernakalant hydrochloride for rapid conversion of atrial fibrillation: a phase 3, randomized, placebo-controlled trial. Circulation 117:1518\u20131525","DOI":"10.1161\/CIRCULATIONAHA.107.723866"},{"key":"300_CR7","doi-asserted-by":"crossref","unstructured":"Pratt CM, Roy D, Torp-Pedersen C, Wyse DG, Toft E, Juul-Moller S, Retyk E, Drenning DH, Atrial Arrhythmia Conversion Trial (ACT-III) Investigators (2010) Usefulness of vernakalant hydrochloride injection for rapid conversion of atrial fibrillation. Am J Cardiol 106:1277\u20131283","DOI":"10.1016\/j.amjcard.2010.06.054"},{"key":"300_CR8","doi-asserted-by":"crossref","unstructured":"Savelieva I, Camm J (2008) Anti-arrhythmic drug therapy for atrial fibrillation: current anti-arrhythmic drugs, investigational agents, and innovative approaches. Europace 10:647\u2013665","DOI":"10.1093\/europace\/eun130"},{"key":"300_CR9","doi-asserted-by":"crossref","unstructured":"Kirchhof P, Andresen D, Bosch R, Borggrefe M, Meinertz T, Parade U, Ravens U, Samol A, Steinbeck G, Treszl A, Wegscheider K, Breithardt G (2012) Short-term versus long-term antiarrhythmic drug treatment after cardioversion of atrial fibrillation (Flec-SL): a prospective, randomised, open-label, blinded endpoint assessment trial. Lancet 380:238\u2013246","DOI":"10.1016\/S0140-6736(12)60570-4"},{"key":"300_CR10","doi-asserted-by":"crossref","unstructured":"Hohnloser SH, Crijns HJGM, Eickels M van, Gaudin C, Page RL, Torp-Pedersen C, Connolly SJ, ATHENA Investigators (2009) Effect of dronedarone on cardiovascular events in atrial fibrillation. N Engl J Med 360:668\u2013678","DOI":"10.1056\/NEJMoa0803778"},{"key":"300_CR11","doi-asserted-by":"crossref","unstructured":"Ha\u00efssaguerre M, Ja\u00efs P, Shah DC, Takahashi A, Hocini M, Quiniou G, Garrigue S, Mouroux A Le, M\u00e9tayer P Le, Cl\u00e9menty J (1998) Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N Engl J Med 339:659\u2013666","DOI":"10.1056\/NEJM199809033391003"},{"key":"300_CR12","doi-asserted-by":"crossref","unstructured":"Wilber DJ, Pappone C, Neuzil P, Paola A De, Marchlinski F, Natale A, Macle L, Daoud EG, Calkins H, Hall B, Reddy V, Augello G, Reynolds MR, Vinekar C, Liu CY, Berry SM, Berry DA (2010) THERMOCOOL AF \u2013 Comparison of antiarrhythmic drug therapy and radiofrequency catheter ablation in patients with paroxysmal atrial fibrillation: a randomized controlled trial. JAMA J Am Med Assoc 303:333\u2013340","DOI":"10.1001\/jama.2009.2029"},{"key":"300_CR13","doi-asserted-by":"crossref","unstructured":"Ja\u00efs P, Cauchemez B, Macle L, Daoud E, Khairy P, Subbiah R, Hocini M, Extramiana F, Sacher F, Bordachar P, Klein G, Weerasooriya R, Cl\u00e9menty J, Ha\u00efssaguerre M (2008) A4 \u2013 Catheter ablation versus antiarrhythmic drugs for atrial fibrillation: the A4 study. Circulation 118:2498\u20132505","DOI":"10.1161\/CIRCULATIONAHA.108.772582"},{"key":"300_CR14","doi-asserted-by":"crossref","unstructured":"Packer DL, Kowal RC, Wheelan KR, Irwin JM, Champagne J, Guerra PG, Dubuc M, Reddy V, Nelson L, Holcomb RG, Lehmann JW, Ruskin JN (2013) STOP AF \u2013 Cryo balloon ablation of pulmonary veins for paroxysmal atrial fibrillation: first results of the North American Arctic front STOP AF Pivotal Trial. J Am Coll Cardiol 61:1713\u20131723","DOI":"10.1016\/j.jacc.2012.11.064"},{"key":"300_CR15","doi-asserted-by":"crossref","unstructured":"Tilz RR, Rillig A, Thum A-M, Arya A, Wohlmuth P, Metzner A, Mathew S, Yoshiga Y, Wissner E, Kuck K-H, Ouyang F (2012) Catheter ablation of long-standing persistent atrial fibrillation: 5-year outcomes of the Hamburg Sequential Ablation Strategy. J Am Coll Cardiol 60:1921\u20131929","DOI":"10.1016\/j.jacc.2012.04.060"},{"key":"300_CR16","doi-asserted-by":"crossref","unstructured":"Camm AJ, Lip GYH, Caterina RD, Savelieva I, Atar D, Hohnloser SH, Hindricks G, Kirchhof P, Bax JJ, Baumgartner H, Ceconi C, Dean V, Deaton C, Fagard R, Funck-Brentano C, Hasdai D, Hoes A, Kirchhof P, Knuuti J, Kolh P, McDonagh T, Moulin C, Popescu BA, Reiner \u017d, Sechtem U, Sirnes PA, Tendera M, Torbicki A, Vahanian A, Windecker S et al (2012) 2012 focused update of the ESC Guidelines for the management of atrial fibrillation. An update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association. Eur Heart J 33:2719\u20132747","DOI":"10.1093\/eurheartj\/ehs253"},{"key":"300_CR17","doi-asserted-by":"crossref","unstructured":"Bash LD, Buono JL, Davies GM, Martin A, Fahrbach K, Phatak H, Avetisyan R, Mwamburi M (2012) Systematic review and meta-analysis of the efficacy of cardioversion by Vernakalant and comparators in patients with atrial fibrillation. Cardiovasc Drugs Ther 26:167\u2013179","DOI":"10.1007\/s10557-012-6374-4"},{"key":"300_CR18","doi-asserted-by":"crossref","unstructured":"Freemantle N, Lafuente-Lafuente C, Mitchell S, Eckert L, Reynolds M (2011) Mixed treatment comparison of dronedarone, amiodarone, sotalol, flecainide, and propafenone, for the management of atrial fibrillation. Europace 13:329\u2013345","DOI":"10.1093\/europace\/euq450"}],"container-title":["Herzschrittmachertherapie + Elektrophysiologie"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00399-014-0300-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00399-014-0300-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00399-014-0300-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T17:16:48Z","timestamp":1559063808000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00399-014-0300-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2,19]]},"references-count":18,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,3]]}},"alternative-id":["300"],"URL":"https:\/\/doi.org\/10.1007\/s00399-014-0300-3","relation":{},"ISSN":["0938-7412","1435-1544"],"issn-type":[{"value":"0938-7412","type":"print"},{"value":"1435-1544","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,2,19]]}}}